Mgb Biopharma

Mgb Biopharma

Mgb Biopharma is a biopharmaceutical company developing anti-infective medicines.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
MGB Biopharma funding round, September 2019
September 2019
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
MGB Biopharma
January 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- MGB Biopharma, a biopharmaceutical company developing MGB-BP-3, a novel antibacterial, for the treatment of Clostridioides difficile (CDI),...
BioSpace
May 19, 2020
BioSpace
MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives, announces that its Phase II clinical study has met its endpoints of safety, efficacy, and dose selection.
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.